A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Advertisement
Advertisement
Trending on AJMC
1
House Republicans Block Vote on ACA Subsidy Extension
2
Study Suggests Adding BTKi to Chemo May Improve Early Outcomes in Richter Transformation in CLL
3
Zasocitinib Hits Phase 3 End Points in Plaque Psoriasis
4
FDA Approval of Subcutaneous Amivantamab Offers Faster, Safer Option for EGFR-Mutated NSCLC
5
